FusionVAC22_01: a phase I clinical trial evaluating a DNAJB1-PRKACA fusion transcript-based peptide vaccine combined with immune checkpoint inhibition for fibrolamellar hepatocellular carcinoma and other tumor entities carrying the oncogenic driver fusion
FusionVAC22_01:一项 I 期临床试验,评估基于 DNAJB1-PRKACA 融合转录本的肽疫苗联合免疫检查点抑制剂治疗纤维板层型肝细胞癌和其他携带致癌驱动融合基因的肿瘤的疗效。
期刊:Frontiers in Oncology
影响因子:3.3
doi:10.3389/fonc.2024.1367450
Hackenbruch, Christopher; Bauer, Jens; Heitmann, Jonas S; Maringer, Yacine; Nelde, Annika; Denk, Monika; Zieschang, Lisa; Kammer, Christine; Federmann, Birgit; Jung, Susanne; Martus, Peter; Malek, Nisar P; Nikolaou, Konstantin; Salih, Helmut R; Bitzer, Michael; Walz, Juliane S